Over €1 million in funding for antimicrobial resistance research


Two research teams at Leiden University have secured over €1 million in funding through the NACTAR programme (Dutch Research Agenda) to explore innovative solutions to antimicrobial resistance (AMR).

Led by Prof. Gilles van Wezel, the first project focuses on unlocking hidden antibiotics from soil bacteria using advanced genome-editing tools. The second, led by Dr. Karina Xavier in collaboration with Wageningen University, investigates how gut microbes can be used to prevent infections by outcompeting harmful bacteria.

Both projects reflect the interdisciplinary strength of the Leiden Bio Science Park and aim to contribute to safer, more effective alternatives to traditional antibiotics.

“These projects show how our research ecosystem is driving solutions to critical global challenges,” said an LBSP spokesperson.

Read more on the Leiden University website.


  • VitroScan Achieves ISO‑15189 Compliance

    A Crucial Step Toward Introducing Predictive Testing Services into Clinical Practice Leiden, The Netherlands, 10 March 2026 — VitroScan is a Dutch biotech company developing predictive ex vivo micro‑tumor testing to help physicians make informed cancer treatment decisions. Today VitroScan announced that…

  • University Sportcentrum has Opened

    The University Sports Centre (USC) has been renovated, and we would love to take you on a quick tour of the building. Whether you are a colleague at LBSP, a student, or an external sports enthusiast: everyone is welcome to…